الفهرس Only 14 pages are availabe for public view
 |  | from | 158 |  |  |
| | | from | 158 | | |
Abstract
Several authors have raised the need to improve the welfare and safety of patients undergoing IVF/ICSI, while maintaining satisfactory pregnancy rates have expressed support for patient-friendly assisted reproduction technology, meaning a policy that is cost-effective, available to the widest possible range of people and minimizes risks and burden for the patient. One way by which the patient{u2019}s experience may be improved is through the use of gonadotrophin-releasing hormone (GnRH) antagonists rather than agonists. Although GnRH antagonists have been used successfully in normal responders in clinics worldwide, most clinics currently use them mainly in patients with unfavourable prognoses (e.g. older patients) or those in whom previous cycles have been unsuccessful. A wide variety of GnRH antagonist protocols have been proposed, reflecting the fact that the protocol is still undergoing refinement. The {u2018}ideal{u2019} protocol is yet to be determined. The present article attempts to address some of these issues and concerns, and proposes a simple GnRH antagonist protocol designed to improve the patient experience